Prevnar 13 Sales Data
| Rank 81 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Prevnar 13 U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 81 ( 7) |
$209,367 | 6.41% | 180 | 6.51% |
| Q3 2013 | 88 ( 3) |
$196,759 | 2.75% | 169 | 3.05% |
| Q2 2013 | 85 (10) |
$191,499 | 6.00% | 164 | 6.49% |
| Q1 2013 | 95 (15) |
$180,661 | -11.69% | 154 | -13.97% |
| Q4 2012 | 80 (14) |
$204,585 | 15.24% | 179 | 13.29% |
| Q3 2012 | 94 (10) |
$177,527 | -5.86% | 158 | -5.39% |
| Q2 2012 | 84 (8) |
$188,578 | 5.30% | 167 | 7.74% |
| Q1 2012 | 92 (4) |
$179,085 | -1.16% | 155 | -5.49% |
| Q4 2011 | 88 (11) |
$181,189 | -6.93% | 164 | -7.87% |
| Q3 2011 | 77 ( ) |
$194,677 | n/a | 178 | n/a |
| Q1 2011 | 60 | $254,201 | n/a | 243 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
